ArticleJournal of cancer research and clinical oncology2023

Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy.

Milad Moloudizargari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.